This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (16)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Darren O'Neill, MD; John Magaldi, MD; Dennis Dobkins, MD; Thomas Greco, MD

Arch Intern Med. 1995;155(3):325-327.

Abstract
The antiphospholipid antibody syndrome has numerous cardiac manifestations, including valvular thickening, insufficiency, and mass lesions. The mass lesions may be confused with atrial myxomas and other vegetations, sometimes necessitating a surgical diagnosis. There are no prospective studies on treatment or follow-up of intracardiac lesions in antiphospholipid antibody syndrome. We prospectively followed up three patients with antiphospholipid antibody syndrome for intracardiac lesions (one atrial and two mitral valve masses) complicated by systemic embolization. Anticoagulation led to complete resolution of the masses in 6 weeks to 3 months. We propose that initial treatment of an intracardiac lesion in patients with antiphospholipid antibody syndrome should be a trial of systemic anticoagulation before surgical intervention.

(Arch Intern Med. 1995;155:325-327)

Author Affiliations
From the University of Connecticut School of Medicine, Farmington (Dr O'Neill); Division of Rheumatology, Yale University School of Medicine, New Haven, Conn (Drs Magaldi and Greco); and Departments of Cardiology (Dr Dobkins) and Rheumatology (Dr Greco), St Mary's Hospital, Waterbury, Conn.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Anti-phospholipid antibodies in patients with multiple sclerosis and MS-like illnesses: MS or APS?
IJdo et al.
Lupus 1999;8:109-115.
ABSTRACT